STEVEN S. COHEN ENDOWED FELLOWSHIP IN ATHEROSCLEROSIS RESEARCH
In 2015 The Heart Foundation established the Steven S. Cohen Endowed Fellowship in Atherosclerosis Research to help train the next generation of extraordinary physician-researchers in cardiac medicine and pave the way for game-changing advances in atherosclerosis prevention. Dr. P.K. Shah serves as the Director of the Endowed Fellowship which resides at Cedars-Sinai Heart Institute. We invite you to meet our current Endowed Fellow – Dr. Xiaoning Zhao.
XIAONING ZHAO, PHD
- Project Scientist, P.K. Shah Laboratory, Cedars-Sinai Medical Center
- Current Holder of The Heart Foundation’s Steven S. Cohen Endowed
Fellowship in Atherosclerosis Research
Xiaoning Zhao, PhD, earned her doctorate in molecular epidemiological science at the Fourth Military Medical University in China. Before coming to the United States, she investigated a DNA vaccine against Hepatitis C Virus at Fourth Military Medical University. She joined the P.K. Shah Laboratory in 2000 and was involved in a variety of research projects, mainly including:
Clarifying the molecular mechanism of atherosclerosis and developing Peptide-based vaccine to reduce atherosclerosis
Demonstrating the inhibitory effect of green tea derived epigallocatechin gallate on vascular smooth muscle cells in vivo and in vitro
Identifying the effect of nitric oxide on proliferation of vascular smooth muscle cells
